FIELD: chemistry.
SUBSTANCE: invention relates to fluorine-containing benzylated isatin of general formula .
EFFECT: obtaining a novel compound which is capable of inducing apoptosis via an internal mitochondrial pathway, thereby inhibiting the growth of cancer cells, which can be used in medicine.
1 cl, 5 dwg, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
FLUORINE-CONTAINING BENZYLATED ISATINS WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2802016C1 |
NEW STERICALLY HINDERED PHENOLS CONTAINING BENZOFUROXAN FRAGMENTS WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2796810C1 |
BROMINE-CONTAINING STERICALLY HINDERED PHENOLS WITH ANTICANCER ACTIVITY | 2023 |
|
RU2822270C1 |
PHOSPHONIUM SALTS BASED ON ALANTOLACTONE, HAVING ANTI-TUMOUR ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2818095C1 |
N,N'-HYDRAZINO-BIS-ISATIN DERIVATIVES WITH ANTITUMOR ACTIVITY | 2023 |
|
RU2796559C1 |
AGENT BASED ON ARGLABIN DERIVATIVE, HAVING SELECTIVE CYTOTOXIC ACTION | 2023 |
|
RU2814738C1 |
PHOSPHORYL SUBSTITUTED 3-KETO-ANDROST-4-ENE-[16,17-D]PYRIDAZINES AND METHOD OF THEIR PREPARATION | 2023 |
|
RU2807870C1 |
AGENT BASED ON ARGLABIN DERIVATIVE, HAVING SELECTIVE CYTOTOXIC ACTION | 2023 |
|
RU2814259C1 |
PHOSPHONIUM SALTS BASED ON BETULINIC ACID, WITH CYTOTOXIC ACTIVITY RELATED TO PROSTATIC ACINOUS CARCINOMA | 2018 |
|
RU2665922C1 |
2-(3-(2-METHYL-6-(P-TOLYL)PYRIDIN-3-YL)UREIDO)BENZENESULFONAMIDE AND DERIVATIVES AS CARBONIC ANHYDRASE INHIBITORS FOR TREATING CANCER | 2020 |
|
RU2815012C1 |
Authors
Dates
2024-03-26—Published
2023-06-02—Filed